Buscar
Mostrando ítems 1-10 de 39
Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections
(Wiley-Blackwell, 2011-02-01)
Purpose: To determine the incidence of rhegmatogenous retinal detachments (RD) after intravitreal injection in six high-volume centres.Methods: A consecutive, interventional, multicenter case series measured the incidence ...
Development of an Experimental Model of Proliferative Retinopathy by Intravitreal Injection of VEGF165
(Mary Ann Liebert, Inc, 2014-11-01)
Purpose: To develop an experimental model of proliferative retinopathy by intravitreal injection of vascular endothelial growth factor 165 (VEGF165) in pigmented rabbits.Methods: A prospective, controlled, comparative ...
Pseudohypopyon immediately after intravitreal injection of triamcinolone acetonide: case reports
(Conselho Brasileiro de Oftalmologia, 2005-04-01)
Report on the development of pseudohypopyon immediately after intravitreal injection of triamcinolone acetonide (TAAC). Two phakic patients presenting with a transient pseudohypopyon after having been treated with intravitreal ...
Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome
(Elsevier B.V., 2004-03-01)
PURPOSE: To report the use of intravitreal injection of acetonide during the acute phase of Vogt-Koyanagi-Harada disease.DESIGN: Prospective interventional case series.METHODS: Three eyes from two patients at the acute ...
Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study)
(B M J Publishing Group, 2008-01-01)
Background/aims: The aim of this study was to compare the morphological and visual acuity outcomes associated with a single intravitreal injection of triamcinolone acetonide versus bevacizumab for the treatment of refractory ...
Twelve-month safety of intravitreal injections of bevacizumab (Avastin (R)): results of the Pan-American Collaborative Retina Study Group (PACORES)
(Springer, 2008-01-01)
Background Vascular endothelial growth factor (VEGF) plays an important role in many diseases of the posterior pole that are characterized by macular edema and/or intraocular neovascularization. Recently anti-VEGF agents ...
Intravitreal Injection of Ziv-Aflibercept in Patient With Refractory Age-Related Macular Degeneration
(Slack Inc, 2015-01-01)
The results of a patient with exudative age-related macular degeneration who received an intravitreal injection of ziv-aflibercept (Zaltrap; Sanofi-Aventis, Paris, France) in the right eye are described. A complete ocular ...
Effects of intravitreal triamcinolone acetonide injection with and without preservative
(B M J Publishing Group, 2007-09-01)
PRIMARY INTRAVITREAL BEVACIZUMAB for SUBFOVEAL CHOROIDAL NEOVASCULARIZATION in AGE-RELATED MACULAR DEGENERATION Results of the Pan-American Collaborative Retina Study Group at 12 Months Follow-up
(Lippincott Williams & Wilkins, 2008-11-01)
Purpose: To report the 12-month anatomic and Early Treatment Diabetic Retinopathy Study best-corrected visual acuity (BCVA) response after primary intravitreal bevacizumab (Avastin(TM), Genentech Inc., San Francisco, CA) ...
Experimental histopathological study on retinal and renal cellular response to intravitreous antiangiogenic drugs
(Ijo Press, 2014-06-18)
AIM: To evaluate histopathological retinal and renal response after one single dose of intravitreous injection of antiangiogenic drugs ranibizumab and bevacizumab in rats.METHODS: Experimental study in 60d of life adults ...